gene therapy - International Biopharmaceutical Industry

Current Edition

Current Features

Subsection - Neurodegenerative Diseases

From Depression to Deep-Learning: Leveraging iPSC and AI Platforms for Evidence-Based Depression Treatment

Subsection - Oncology

Essential DMPK Strategies for IND Success

Subsection - Cell and Gene Therapy

When the Gene Editing Guide is the Drug

news

FDA halts tests of BioMarin drug amid heightened focus on gene therapy safety

The theoretical risk that gene therapy may cause cancer in humans has hung over the field for decades. Those worries resurfaced last year when a liver tumor was spott...

10 September 2021 news BioMarin | cancer

Continue Reading →

news

FDA clears Rocket to resume testing gene therapy for a rare heart disease

Rocket's program has been in limbo since early May, when the company surprised investors and analysts with news of the trial's stoppage. That announcement stalled wh...

20 August 2021 news Bluebird | FDA

Continue Reading →

news

Oxford Genetics signs licensing agreement with Aldevron to market lentiviral packaging plasmids

Oxford Genetics, a leading innovator of biopharmaceutical technologies, has signed a licensing agreement with world-class service organization, Aldevron to bring to m...